Non-invasive prenatal testing for Down syndrome

被引：26

作者：

Twiss, Philip ^{[1
]}

Hill, Melissa ^{[1
]}

Daley, Rebecca ^{[1
]}

Chitty, Lyn S. ^{[1
,2
]}

机构：

[1] Great Ormond St Hosp Children NHS Fdn Trust, NE Thames Reg Genet Serv, London WC1N 3BH, England

[2] UCL Inst Child Hlth, London WC1N 1EH, England

来源：

SEMINARS IN FETAL & NEONATAL MEDICINE | 2014年 / 19卷 / 01期

关键词：

Cell-free fetal DNA; Down syndrome; Fetal aneuploidy; Non-invasive prenatal testing; Prenatal diagnosis; FREE FETAL DNA; CELL-FREE DNA; SINGLE-GENE DISORDERS; MATERNAL PLASMA; CLINICAL UTILITY; WHOLE GENOME; DIAGNOSIS; ANEUPLOIDY; BLOOD; WOMEN;

D O I：

10.1016/j.siny.2013.10.003

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Prenatal screening and diagnosis of Down syndrome and other major aneuploidies may be transformed following the identification of cell-free fetal DNA in maternal plasma at the end of the last millennium. Next generation sequencing has enabled the development of tests that accurately predict the presence of fetal trisomies by analysis of cell-free DNA in maternal blood from as early as 10 weeks of gestation. These tests are now widely available in the commercial sector but are yet to be implemented in publicly led health services. In this article we discuss the technical, social, and ethical challenges that these new tests bring. (C) 2013 Elsevier Ltd. All rights reserved.

引用

页码：9 / 14

页数：6

共 67 条

[1] Commercial landscape of noninvasive prenatal testing in the United States
Agarwal, Ashwin
Sayres, Lauren C.
Cho, Mildred K.
Cook-Deegan, Robert
Chandrasekharan, Subhashini
[J]. PRENATAL DIAGNOSIS, 2013, 33 (06) : 521 - 531
[2] Best ethical practices for clinicians and laboratories in the provision of noninvasive prenatal testing
Allyse, M. A.
Sayres, L. C.
Havard, M.
King, J. S.
Greely, H. T.
Hudgins, L.
Taylor, J.
Norton, M. E.
Cho, M. K.
Magnus, D.
Ormond, K. E.
[J]. PRENATAL DIAGNOSIS, 2013, 33 (07) : 656 - 661
[3] Cell-free fetal DNA testing for fetal aneuploidy and beyond: clinical integration challenges in the US context
Allyse, Megan
Sayres, Lauren C.
King, Jaime S.
Norton, Mary E.
Cho, Mildred K.
[J]. HUMAN REPRODUCTION, 2012, 27 (11) : 3123 - 3131
[4] Noninvasive Prenatal Testing for Fetal Aneuploidy
不详
[J]. OBSTETRICS AND GYNECOLOGY, 2012, 120 (06) : 1532 - 1534
[5] Trisomy 13 detection in the first trimester of pregnancy using a chromosome-selective cell-free DNA analysis method
Ashoor, G.
Syngelaki, A.
Wang, E.
Struble, C.
Oliphant, A.
Song, K.
Nicolaides, K. H.
[J]. ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2013, 41 (01) : 21 - 25
[6] Chromosome-selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18
Ashoor, Ghalia
Syngelaki, Argyro
Wagner, Marion
Birdir, Cahit
Nicolaides, Kypros H.
[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2012, 206 (04) : 322.e1 - 322.e5
[7] Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011
Benn, Peter
Borrell, Antoni
Cuckle, Howard
Dugoff, Lorraine
Gross, Susan
Johnson, Jo-ann
Maymon, Ron
Odibo, Anthony
Schielen, Peter
Spencer, Kevin
Wright, Dave
Yaron, Yuval
[J]. PRENATAL DIAGNOSIS, 2012, 32 (01) : 1 - 2
[8] Genome-Wide Fetal Aneuploidy Detection by Maternal Plasma DNA Sequencing
Bianchi, Diana W.
Platt, Lawrence D.
Goldberg, James D.
Abuhamad, Alfred Z.
Sehnert, Amy J.
Rava, Richard P.
[J]. OBSTETRICS AND GYNECOLOGY, 2012, 119 (05) : 890 - 901
[9] From Michael to microarrays: 30 years of studying fetal cells and nucleic acids in maternal blood
Bianchi, Diana W.
[J]. PRENATAL DIAGNOSIS, 2010, 30 (07) : 622 - 623
[10] Benefits and limitations of whole genome versus targeted approaches for noninvasive prenatal testing for fetal aneuploidies
Boon, Elles M. J.
Faas, Brigitte H. W.
[J]. PRENATAL DIAGNOSIS, 2013, 33 (06) : 563 - 568

← 1 2 3 4 5 6 7 →